News Articles Network

Health and Fitness
RSS FeedJSON FeedXML FeedCSV Feed
Sat, June 10, 2017
[ 07:57am GMT ] - Country: United States, Market Wire
Lilly's Galcanezumab Significantly Reduc .. ine: New Results Presented a
Sat, June 3, 2017
[ 08:24am GMT ] - Country: United States, Market Wire
Lilly Builds Upon Body of Data for Abema .. Progression-Free Survival in
Wed, May 31, 2017
[ 01:12am GMT ] - Country: United States, Market Wire
Lilly Announces Phase 3 RANGE Urothelial .. , Improving Progression-Free
Wed, May 17, 2017
[ 11:58am GMT ] - Country: United States, Market Wire
Lilly to Present Results from Pivotal Br .. Portfolio Data at ASCO 2017
Fri, May 12, 2017
[ 00:58am GMT ] - Country: United States, Market Wire
Lilly Announces Positive Results for Thr .. pisodic and Chronic Migraine
Thu, May 11, 2017
[ 10:26am GMT ] - Country: United States, Market Wire
BioLife Solutions Announces Q1 2017 Financial Results
Tue, May 9, 2017
[ 10:12am GMT ] - Country: United States, Market Wire
FDA Grants BAVENCIO (avelumab) Approval .. e of Advanced Bladder Cancer
Thu, May 4, 2017
[ 00:43am GMT ] - Country: United States, Market Wire
BioLife Solutions to Report First Quarte .. iness Update on May 11, 2017
Thu, April 20, 2017
[ 06:04am GMT ] - Country: United States, Market Wire
Lilly to Present Data for Galcanezumab f .. urology (AAN) Annual Meeting
Fri, April 14, 2017
[ 03:19am GMT ] - Country: United States, Market Wire
U.S. FDA Issues Complete Response Letter for Baricitinib
Thu, March 23, 2017
[ 06:18am GMT ] - Country: United States, Market Wire
Lilly and the William Sansum Diabetes Ce .. -year research collaboration
Fri, March 17, 2017
[ 02:04am GMT ] - Country: United States, Market Wire
First dedicated outcome trials of empagl .. onic heart failure initiated
Thu, March 9, 2017
[ 13:05pm GMT ] - Country: United States, Market Wire
BioLife Solutions Reports 4th Quarter and Full Year 2016 Results
Sat, March 4, 2017
[ 06:20am GMT ] - Country: United States, Market Wire
New Head-to-Head Data Shows Significantl .. ared to Stelara (ustekinumab
Fri, March 3, 2017
[ 11:45am GMT ] - Country: United States, Market Wire
Lilly Diabetes Becomes 'Official Diabetes Health Partner of NASCAR'

BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May 11, 2017

Published on 2017-05-04 03:44:55 - Market Wire
  Print publication without navigation

BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May

BOTHELL, Wash., May 4, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media ("BioLife" or the "Company"), today announced that the Company's first quarter 2017 financial results will be released after market close on Thursday, May 11, 2017, and that the Company will host a conference call and live webcast at 1:30 p.m. PT that afternoon. Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log on to the Investor Relations page of the BioLife Solutions website at www.biolifesolutions.com. Alternatively, you may access the live conference call by dialing (844) 825-0512 (U.S. &Canada) or (315) 625-6880 (International) with the following Conference ID: 17308601. A webcast replay will be available approximately two hours after the call and will be archived on www.biolifesolutions.com for 90 days.

About BioLife Solutions

The Company's proprietary HypoThermosol and CryoStor platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife's biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife's enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.

For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

Media & Investor Relations

Roderick de Greef

Chief Financial Officer

(425) 402-1400

rdegreef@biolifesolutions.com

SOURCE BioLife Solutions, Inc.



RELATED LINKS

http://www.biolifesolutions.com


Contributing Sources

Market Wire
cs@marketwire.com